Clinical Trial Update: Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating interleukin-12 gene therapy in patients with liver metastases from colorectal cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Interleukin-12 gene therapy (interleukin-12 gene therapy)

Snippet

Sponsor: Max Sung | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 1 | Status: TERMINATED